Skip to content
Sign in

MOLN · NASDAQ

Molecular Partners AG (MOLN) Stock Price & Fundamentals

$558.40+0.54%+$2.98End-of-day price as of Oct 9, 2026

Molecular Partners AG (MOLN) closed at $558.40 on Oct 9, 2026, up 0.54% from the previous close of $555.42.

Share price, past year

1Y +12.09%
Daily closing prices

52-week range $498.18 – $570.94.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$558.40
Sep 30, 2026$549.97
Aug 31, 2026$545.09
Jul 31, 2026$539.62
Jun 30, 2026$557.42
May 29, 2026$546.59
Apr 30, 2026$545.62
Mar 31, 2026$528.29
Feb 27, 2026$516.56
Jan 30, 2026$529.89
Dec 31, 2025$501.65
Nov 28, 2025$516.61
Oct 31, 2025$505.87

Key statistics

Market cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Net income (TTM)
—
Shares outstanding
40.4M
Dividend yield
—
52-week range
$498.18 – $570.94

Market cap, P/E and dividend yield aren't shown for Molecular Partners AG yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Swiss francs.

Financials

Molecular Partners AG reported revenue of CHF 0.00 for fiscal 2025, down 100.00% from fiscal 2024.

Figures are in Swiss francs (CHF), as Molecular Partners AG reports them to the SEC.

Annual revenue

FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Molecular Partners AG annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025CHF 0.00−100.0%——−CHF 1.65−CHF 51.97M
FY2024ended Dec 31, 2024CHF 4.97M−29.4%——−CHF 1.59−CHF 59.95M
FY2023ended Dec 31, 2023CHF 7.04M−96.3%——−CHF 1.89−CHF 59.58M
FY2022ended Dec 31, 2022CHF 189.60M+1,843.8%——CHF 3.54CHF 117.39M
FY2021ended Dec 31, 2021CHF 9.75M+4.4%——−CHF 2.06−CHF 91.89M
FY2020ended Dec 31, 2020CHF 9.34M−54.2%——−CHF 2.51−CHF 30.43M
FY2019ended Dec 31, 2019CHF 20.38M———−CHF 1.69−CHF 2.22M
Molecular Partners AG quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2025ended Jun 30, 2025CHF 0.00—−CHF 0.56
Q2 FY2024ended Jun 30, 2024CHF 1.55M—−CHF 0.46
Q2 FY2023ended Jun 30, 2023CHF 415.00K—−CHF 0.49
Q2 FY2022ended Jun 30, 2022CHF 11.76M—−CHF 0.14

Company profile

Name
Molecular Partners AG
Ticker
MOLN
Exchange
NASDAQ
Industry (SEC SIC)
Biological Products, (No Diagnostic Substances)
Headquarters
Wagistrasse 14, Schlieren-Zurich, V8 8952
Incorporated in
V8
Fiscal year ends
December
SEC CIK
0001745114

Recent SEC filings

Frequently asked questions

What is Molecular Partners AG's stock price?

Molecular Partners AG (MOLN) closed at $558.40 on Oct 9, 2026, up 0.54% from the previous close of $555.42.

How much revenue does Molecular Partners AG make?

Molecular Partners AG reported revenue of CHF 0.00 for fiscal 2025, down 100.00% from fiscal 2024.

Sources and methodology

Fundamentals come from Molecular Partners AG's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures